Stephen Markwell
Papers
1
Total Citations
15
H-Index
1
About
Dr. Stephen Markwell is a leading figure in thoracic surgical oncology, with a focused research program dedicated to optimizing perioperative pain management and enhancing recovery in minimally invasive thoracic surgery. His most cited work, a 2022 randomized trial comparing bupivacaine to liposomal bupivacaine in minimally invasive lobectomy, has garnered 15 citations and represents a pivotal contribution to evidence-based regional anesthesia. This study directly addresses a critical clinical question—whether extended-release local anesthetics offer superior analgesia and reduce opioid consumption in lung cancer patients—providing actionable data that has influenced postoperative protocols. Dr. Markwell’s research bridges the gap between surgical technique and patient-centered outcomes, emphasizing the importance of multimodal pain control in reducing hospital stays and improving quality of life. His work is notable for its rigorous methodology and direct applicability to the operating room, making him a respected voice in the movement toward standardized, opioid-sparing care in thoracic surgery. Through these contributions, Dr. Markwell continues to shape best practices for the thousands of patients undergoing lung resection each year.
Research Focus
Key Achievements
Top Papers
- 1